|November 21, 2013||
The opinion of Hungarian Association of Oral and Maxillofacial Surgeons on the justification of supportive treatment of patients with tumorous diseases of the oral cavity
Hungarian Medical Journal
For patients suffering from head- and neck tumors – primarily malignant tumorous diseases of the oral cavity, the progression of the disease can be slowed significantly, the five-year survival rate increased considerably, the quality of life improved, and the oxidative stress on the patients reduced by the long-term application of the supplementary formula Avemar. The Association considers the supportive treatment with the formula Avemar as an important part of the complextherapeutic protocols applied in stages II, III and IV of malignant tumorous diseases of the oral cavity.
To view this article, we ask that you sign-in below.
If you are new here -OR- haven’t registered yet, simply sign-up with us below for free!
Want More Articles Like This?
Visit The Integrative Oncology Learning Center